News

Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis
Vertex Pharmaceuticals today announced that Health Canada has granted Marketing Authorization for PrALYFTREKTM ...
A Look At The Fair Value Of Vertex, Inc. (NASDAQ:VERX)
Key Insights The projected fair value for Vertex is US$39.89 based on 2 Stage Free Cash Flow to Equity Current ...